Pall completes $375M Senior Notes offering

Pall Corporation (NYSE: PLL) today announced that it has completed the previously announced public offering of its $375 million aggregate principal amount of 5.00% Senior Notes due June 15, 2020.

Pall plans to use the net proceeds from this offering to redeem the $280 million aggregate principal amount of its outstanding 6% Senior Notes due 2012 and for general corporate purposes.

Banc of America Securities LLC and J.P. Morgan Securities Inc. are acting as joint bookrunning managers for the offering of notes.

Posted in:

Tags:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Pall Corporation. (2019, June 24). Pall completes $375M Senior Notes offering. News-Medical. Retrieved on December 25, 2024 from https://www.news-medical.net/news/20100619/Pall-completes-24375M-Senior-Notes-offering.aspx.

  • MLA

    Pall Corporation. "Pall completes $375M Senior Notes offering". News-Medical. 25 December 2024. <https://www.news-medical.net/news/20100619/Pall-completes-24375M-Senior-Notes-offering.aspx>.

  • Chicago

    Pall Corporation. "Pall completes $375M Senior Notes offering". News-Medical. https://www.news-medical.net/news/20100619/Pall-completes-24375M-Senior-Notes-offering.aspx. (accessed December 25, 2024).

  • Harvard

    Pall Corporation. 2019. Pall completes $375M Senior Notes offering. News-Medical, viewed 25 December 2024, https://www.news-medical.net/news/20100619/Pall-completes-24375M-Senior-Notes-offering.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pall, NIBRT co-host master class on single-use systems in manufacturing of biopharmaceuticals